PRKCD and systemic lupus erythematosus: In systemic lupus erythematosus (SLE), PKCδ deficiency results in impaired B cell apoptosis, loss of immune tolerance, and subsequent disease progression [260], while indirectly participating in SLE‐associated inflammatory responses through regulation of the IFN/STAT1 pathway [261].